Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RONALD N SHORE

Allopathic & Osteopathic Physicians Dermatology

NPI
1144258757
CMS profile
566358
Location
ROCKVILLE, MD

General Payments · PY2018–2024

$104,500.21

  • Reported across 154 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$885.82

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $744.83 33
Education $140.99 2

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $230.86 8
Janssen Biotech, Inc. $173.69 5
Dermavant Sciences, Inc. $169.12 9
UCB, Inc. $64.07 3
ABBVIE INC. $62.17 3
GENZYME CORPORATION $56.71 2
PFIZER INC. $36.06 1
Regeneron Healthcare Solutions, Inc. $26.33 1
E.R. Squibb & Sons, L.L.C. $24.69 1
Amgen Inc. $22.48 1
Arcutis Biotherapeutics, Inc. $19.64 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $131.88 7
PY2019 $2,154.76 17
PY2020 $266.45 11
PY2021 $79,287.04 23
PY2022 $20,569.74 23
PY2023 $1,204.52 38
PY2024 $885.82 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $16.27 07/01/2024 Food and Beverage Undisputed 01/23/2026 1106091324 CMS
ABBVIE INC. $22.85 08/20/2024 Food and Beverage Undisputed 01/23/2026 1106091326 CMS
ABBVIE INC. $23.05 11/13/2024 Food and Beverage Undisputed 01/23/2026 1106091328 CMS
Amgen Inc. $22.48 05/09/2024 Food and Beverage Undisputed 01/23/2026 1117683382 CMS
Arcutis Biotherapeutics, Inc. $19.64 01/11/2024 Food and Beverage Undisputed 01/23/2026 1121071226 CMS
Dermavant Sciences, Inc. $26.17 01/30/2024 Food and Beverage Undisputed 01/23/2026 1127933471 CMS
Dermavant Sciences, Inc. $6.04 03/07/2024 Food and Beverage Undisputed 01/23/2026 1127933474 CMS
Dermavant Sciences, Inc. $20.59 03/18/2024 Food and Beverage Undisputed 01/23/2026 1127933478 CMS
Dermavant Sciences, Inc. $24.70 04/09/2024 Food and Beverage Undisputed 01/23/2026 1127933482 CMS
Dermavant Sciences, Inc. $20.22 05/14/2024 Food and Beverage Undisputed 01/23/2026 1127933486 CMS
Dermavant Sciences, Inc. $20.96 06/28/2024 Food and Beverage Undisputed 01/23/2026 1127933490 CMS
Dermavant Sciences, Inc. $20.60 09/06/2024 Food and Beverage Undisputed 01/23/2026 1127933493 CMS
Dermavant Sciences, Inc. $7.50 10/08/2024 Food and Beverage Undisputed 01/23/2026 1127933497 CMS
Dermavant Sciences, Inc. $22.34 12/19/2024 Food and Beverage Undisputed 01/23/2026 1127933501 CMS
E.R. Squibb & Sons, L.L.C. $24.69 05/14/2024 Food and Beverage Undisputed 01/23/2026 1101311011 CMS
GENZYME CORPORATION $38.71 05/15/2024 Food and Beverage Undisputed 01/23/2026 1139581418 CMS
GENZYME CORPORATION $18.00 07/02/2024 Food and Beverage Undisputed 01/23/2026 1139581446 CMS
Janssen Biotech, Inc. $6.27 03/15/2024 Food and Beverage Undisputed 01/23/2026 1078728444 CMS
Janssen Biotech, Inc. $8.61 04/22/2024 Food and Beverage Undisputed 01/23/2026 1078727956 CMS
Janssen Biotech, Inc. $72.00 06/28/2024 Education Undisputed 01/23/2026 1078728113 CMS
Janssen Biotech, Inc. $17.82 08/21/2024 Food and Beverage Undisputed 01/23/2026 1078727924 CMS
Janssen Biotech, Inc. $68.99 11/15/2024 Education Undisputed 01/23/2026 1078728496 CMS
Lilly USA, LLC $5.93 01/11/2024 Food and Beverage Undisputed 01/23/2026 1135374940 CMS
Lilly USA, LLC $19.31 01/17/2024 Food and Beverage Undisputed 01/23/2026 1135377184 CMS
Lilly USA, LLC $7.22 02/05/2024 Food and Beverage Undisputed 01/23/2026 1135401483 CMS
Lilly USA, LLC $27.47 04/03/2024 Food and Beverage Undisputed 01/23/2026 1135390603 CMS
Lilly USA, LLC $27.29 06/13/2024 Food and Beverage Undisputed 01/23/2026 1135338929 CMS
Lilly USA, LLC $5.79 09/10/2024 Food and Beverage Undisputed 01/23/2026 1135338933 CMS
Lilly USA, LLC $121.54 12/04/2024 Food and Beverage Undisputed 01/23/2026 1135358156 CMS
Lilly USA, LLC $16.31 12/09/2024 Food and Beverage Undisputed 01/23/2026 1135390601 CMS
PFIZER INC. $36.06 05/08/2024 Food and Beverage Undisputed 01/23/2026 1131550233 CMS
Regeneron Healthcare Solutions, Inc. $26.33 09/13/2024 Food and Beverage Undisputed 01/23/2026 1114171154 CMS
UCB, Inc. $22.17 07/30/2024 Food and Beverage Undisputed 01/23/2026 1143086572 CMS
UCB, Inc. $24.13 09/19/2024 Food and Beverage Undisputed 01/23/2026 1143086574 CMS
UCB, Inc. $17.77 10/17/2024 Food and Beverage Undisputed 01/23/2026 1143086576 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.